Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients with Atrial Fibrillation: A Report from the GARFIELD-AF Registry

Medicine and Dentistry

• ACE Inhibitor 14%
• Angiotensin Receptor Antagonist 14%
• Antiplatelet 14%
• Antiplatelet Drug 21%
• Antithrombotic 35%
• Apoplexy 21%
• Atrial Fibrillation 100%
• Cardiovascular System 21%
• Cause of Death 7%
• Congestive Heart Failure 21%
• Hazard Ratio 7%
• Ischemic Cardiomyopathy 92%
• Major Bleeding 14%
• Mortality Rate 7%
• Nonischemic Cardiomyopathy 100%
• Patient with Congestive Heart Failure 7%

Pharmacology, Toxicology and Pharmaceutical Science

• Angiotensin Receptor Antagonist 14%
• Anticoagulant Agent 35%
• Antiplatelet 14%
• Antithrombocytic Agent 21%
• Atrial Fibrillation 100%
• Bleeding 14%
• Cause of Death 7%
• Congestive Heart Failure 28%
• Dipeptidyl Carboxypeptidase Inhibitor 14%
• Ischemic Cardiomyopathy 92%
• Mortality Rate 7%
• Nonischemic Cardiomyopathy 100%

Keyphrases

• Bleeding Rate 7%
• Heart Failure Therapy 7%
• Oral Anticoagulant Drugs 7%
• Oral Antiplatelet Agents 7%